Cortes-Camacho F, Zambrano-Vasquez O, Arechaga-Ocampo E, Castaneda-Sanchez J, Gonzaga-Sanchez J, Sanchez-Gloria J
Antioxidants (Basel). 2024; 13(7).
PMID: 39061837
PMC: 11274291.
DOI: 10.3390/antiox13070768.
Echefu G, Stowe I, Burka S, Basu-Ray I, Kumbala D
Front Nephrol. 2023; 3:1198560.
PMID: 37840653
PMC: 10570458.
DOI: 10.3389/fneph.2023.1198560.
Stojanovic D, Stojanovic M, Milenkovic J, Velickov A, Ignjatovic A, Milojkovic M
Cells. 2023; 12(12).
PMID: 37371077
PMC: 10297141.
DOI: 10.3390/cells12121607.
Rasmussen M, Hansen K, Scholze A
Antioxidants (Basel). 2023; 12(4).
PMID: 37107307
PMC: 10135793.
DOI: 10.3390/antiox12040932.
Ibrahim R, Abdelhafez H, El-Shamy S, Eid F, Mashaal A
Sci Rep. 2023; 13(1):5005.
PMID: 36973339
PMC: 10042862.
DOI: 10.1038/s41598-023-31897-x.
Renoprotective potentials of small molecule natural products targeting mitochondrial dysfunction.
Rahman M, Akter S, Dorotea D, Mazumder A, Uddin M, Hannan M
Front Pharmacol. 2022; 13:925993.
PMID: 35910356
PMC: 9334908.
DOI: 10.3389/fphar.2022.925993.
Nrf2 Activation in Chronic Kidney Disease: Promises and Pitfalls.
Aranda-Rivera A, Cruz-Gregorio A, Pedraza-Chaverri J, Scholze A
Antioxidants (Basel). 2022; 11(6).
PMID: 35740009
PMC: 9220138.
DOI: 10.3390/antiox11061112.
Involvement of Inflammasome Components in Kidney Disease.
Aranda-Rivera A, Srivastava A, Cruz-Gregorio A, Pedraza-Chaverri J, Mulay S, Scholze A
Antioxidants (Basel). 2022; 11(2).
PMID: 35204131
PMC: 8868482.
DOI: 10.3390/antiox11020246.
Prospects for Protective Potential of against Kidney Diseases.
Akter T, Rahman M, Moni A, Apu M, Fariha A, Hannan M
Plants (Basel). 2021; 10(12).
PMID: 34961289
PMC: 8706354.
DOI: 10.3390/plants10122818.
A nano based approach to alleviate cisplatin induced nephrotoxicity.
Anees L, Abdel-Hamid G, Elkady A
Int J Immunopathol Pharmacol. 2021; 35:20587384211066441.
PMID: 34915755
PMC: 8725228.
DOI: 10.1177/20587384211066441.
Mitochondrial Targeting of Herbal Medicine in Chronic Kidney Disease.
Li Q, Xing C, Yuan Y
Front Pharmacol. 2021; 12:632388.
PMID: 34122064
PMC: 8188236.
DOI: 10.3389/fphar.2021.632388.
Pleiotropic Effects of Eugenol: The Good, the Bad, and the Unknown.
Aburel O, Pavel I, Danila M, Lelcu T, Roi A, Lighezan R
Oxid Med Cell Longev. 2021; 2021:3165159.
PMID: 33747344
PMC: 7943301.
DOI: 10.1155/2021/3165159.
Implications of Oxidative Stress and Potential Role of Mitochondrial Dysfunction in COVID-19: Therapeutic Effects of Vitamin D.
de Las Heras N, Gimenez V, Ferder L, Manucha W, Lahera V
Antioxidants (Basel). 2020; 9(9).
PMID: 32967329
PMC: 7555731.
DOI: 10.3390/antiox9090897.
Temporal Alterations in Mitochondrial β-Oxidation and Oxidative Stress Aggravate Chronic Kidney Disease Development in 5/6 Nephrectomy Induced Renal Damage.
Aparicio-Trejo O, Rojas-Morales P, Avila-Rojas S, Leon-Contreras J, Hernandez-Pando R, Jimenez-Uribe A
Int J Mol Sci. 2020; 21(18).
PMID: 32899919
PMC: 7555424.
DOI: 10.3390/ijms21186512.
Mitochondrial DNA: A New Predictor of Diabetic Kidney Disease.
Huang Y, Chi J, Wei F, Zhou Y, Cao Y, Wang Y
Int J Endocrinol. 2020; 2020:3650937.
PMID: 32733553
PMC: 7378596.
DOI: 10.1155/2020/3650937.
Heme-Oxygenase and Kidney Transplantation: A Potential for Target Therapy?.
Corona D, Ekser B, Gioco R, Caruso M, Schipa C, Veroux P
Biomolecules. 2020; 10(6).
PMID: 32486245
PMC: 7355572.
DOI: 10.3390/biom10060840.
(-)-Epigallocatechin-3-gallate (EGCG) attenuates salt-induced hypertension and renal injury in Dahl salt-sensitive rats.
Luo D, Xu J, Chen X, Zhu X, Liu S, Li J
Sci Rep. 2020; 10(1):4783.
PMID: 32179848
PMC: 7075996.
DOI: 10.1038/s41598-020-61794-6.
Inflammation and Oxidative Stress in Chronic Kidney Disease-Potential Therapeutic Role of Minerals, Vitamins and Plant-Derived Metabolites.
Rapa S, Di Iorio B, Campiglia P, Heidland A, Marzocco S
Int J Mol Sci. 2020; 21(1).
PMID: 31906008
PMC: 6981831.
DOI: 10.3390/ijms21010263.
Molecular Mechanisms of Epigallocatechin-3-Gallate for Prevention of Chronic Kidney Disease and Renal Fibrosis: Preclinical Evidence.
Kanlaya R, Thongboonkerd V
Curr Dev Nutr. 2019; 3(9):nzz101.
PMID: 31555758
PMC: 6752729.
DOI: 10.1093/cdn/nzz101.
Ginsenoside Rb3 provides protective effects against cisplatin-induced nephrotoxicity via regulation of AMPK-/mTOR-mediated autophagy and inhibition of apoptosis in vitro and in vivo.
Xing J, Hou J, Ma Z, Wang Z, Ren S, Wang Y
Cell Prolif. 2019; 52(4):e12627.
PMID: 31094028
PMC: 6668974.
DOI: 10.1111/cpr.12627.